Fort Lauderdale, Florida–(Newsfile Corp. – August 1, 2023) – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a consumer-packaged goods leader serving all 50 states and 13 countries with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, is proud to announce that it has entered an exclusive worldwide partnership with WWE legend Hulk Hogan.

Flora will launch legendary superstar Hulk Hogan’s comprehensive consumer products portfolio through Just Brands. Under the agreement, Flora will produce and sell Hulk Hogan products globally, including Hulk Hogan’s hemp-derived pre-rolls, topicals, flower, edibles, CBD, HHC, Delta 8, and Kratom.

“Flora is thrilled to be selected as the exclusive producer for Hulk Hogan products,” said Clifford Starke, Chief Executive Officer of Flora. “Our award-winning products and Hulk Hogan’s status as an icon and American hero will make us the ultimate championship tag team.”

“Our exclusive partnership with Flora allows us to deliver Hulk Hogan’s vision of a premier brand to the consumer,” noted Hulk Hogan, the face of iconic trademarks including “Hulk Hogan,” “Hulkamania,” “Hollywood Hulk Hogan,” and the “Hulkster.”

“I am excited to stand behind my brand with Flora. I used to tell my Hulkamaniacs to say their prayers, take their vitamins, and they will never go wrong. Well, let me tell you something, brother. Flora is the ideal partner to make my CBD-infused vitamins,” stated Hulk Hogan.

Chad Bronstein, Chairman and President of Carma HoldCo, the leader in licensing for legends and the holding company of iconic brands such as Mike Tyson’s “Tyson 2.0,” Ric Flair’s “Ric Flair Drip,” “Immortal by Hulk Hogan,” and others, said this about the partnership:

“We are excited to join forces with Flora to bring Hulk Hogan’s iconic brand to new global audiences. When you take Flora’s vast distribution network, our ability to create one-of-a-kind consumer experiences, with Hulk Hogan’s status and legacy, all roads lead to legendary.”

The exclusive agreement has an initial term of three years with mutually agreed-upon consecutive one-year renewal periods. The anticipated initial 24-month top-line sales pilot target is $20 million. Flora is expected to pay a royalty and a license fee for the sales of Hulk Hogan-branded products.

**Use Promo Code HULK to Earn 10% Off Your Next Purchase**

About Hulk Hogan

Hulk Hogan is a pop-culture icon widely regarded as the greatest professional wrestler of all time. The American Hero entertained and inspired tens of millions worldwide for over 35 years, transcending the ring and ushering in the new era of global sports entertainment as we know it today. The Hulk Hogan phenomenon was the first of its kind-and remains an ever-present influence today, generations later.

Hulk Hogan headlined eight editions of WWE’s signature event Wrestlemania and reigned as champion for a record-setting 1,474 days, one of the longest in the promotion’s history. His match with Andre the Giant still holds the American television viewership records for wrestling with 33 million viewers. His crossover appeal led to notable acting roles spanning film and television, including appearances in Rocky III, No Holds Barred, Suburban Commando, and the acclaimed Hogan Knows Best.

About Carma HoldCo Inc.

Carma HoldCo Inc. (Carma) creates iconic global brands through licensing and is the brand house behind Mike Tyson’s “TYSON 2.0,” Ric Flair’s “Rich Flair Drip,” two-time GRAMMY winner Future’s “EVOL by Future,” and “Immortal by Hulk Hogan.” Carma product distribution spans over 100,000 retailers across 40 states, select Canadian provides, and 17 countries worldwide. For more information on Carma HoldCo, visit www.carmahold.com

About Flora Growth Corp.

Flora Growth Corp. is a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries. In the United States, Flora’s lifestyle business has established a robust presence across all 50 states, providing us with a solid foundation. Furthermore, we believe we possess substantial potential for international expansion. Based in Germany, we have successfully developed a strong distribution network delivering lifestyle and wellness products to 28 countries. For more information, kindly visit www.floragrowth.com or follow @floragrowthcorp on social media.

Cannot view this image? Visit:
https://images.newsfilecorp.com/files/9845/175654_1.jpeg

http://floragrowth.com/

https://justcbdstore.com/

https://www.vesselbrand.com/

https://justcbdstore.uk/

https://www.phatebo.de/home-en

Investor Relations:

Investor Relations ir@floragrowth.com

Clifford Starke Clifford.Starke@floragrowth.com

Media:

media@floragrowth.com

Cautionary Statement Concerning Forward-Looking Statements

This press release contains “forward-looking statements,” as defined by federal securities laws. Forward-looking statements reflect Flora’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled “Risk Factors” in Flora’s Annual Report on Form 10K filed with the SEC on March 31, 2023, as such factors may be updated from time to time in Flora’s periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora’s filings with the SEC. While forward-looking statements reflect Flora’s good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Figure 2: Keylime Kush by Lotus Cannabis Co.

This milestone is a long-time coming for our team of Okanagan legacy growers led by Carl Correia and Jason Brown and is another catalyst in the Lotus sales evolution this year. Lotus has also applied for three additional provincial product calls and continues to utilize the business-to-business wholesale market when favourable. Lotus’ Keylime Kush is now listed in British Columbia, with the Black Blossom listed in British Columbia, Alberta, and Manitoba with Pistol and Paris, and with the Kalifornia and Tranquil Elephantizer listed in Ontario.

For more information on the Keylime Kush and our other Lotus-grown cultivars, please visit lotuscannabis.ca/flower

ON BEHALF OF LOTUS VENTURES INC:
Lotus Ventures Inc.
“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.
Lotus Ventures Inc. is a BC-based licensed producer of premium cannabis. Lotus owns the premium-craft consumer brand Lotus Cannabis Co. which has had its cannabis flower sold by wholesale partners in all provinces to date. Lotus is an experienced cultivator on a mission to produce the cleanest and most consistent premium cannabis in Canada. With operations in the North Okanagan B.C., the Lotus Cannabis team has launched popular cultivars like the Keylime Kush, Black Blossom, Tranquil Elephantizer and Kalifornia and currently has flower being sold in British Columbia, Alberta, Manitoba, and Ontario.

To invest in the Company, Lotus Ventures Inc. is listed on the Canadian Securities Exchange (CSE:J), on the OTC Markets (OTC:LTTSF) and on the Frankfurt Stock Exchange (FRA:LV9).

For More Information:

President & CEO
Dale McClanaghan
(604) – 644 – 9844

Investor Relations & Communications
Daniel McRobert
[email protected]
(604) – 842 – 4625

General Information
[email protected]
(604) – 842 – 4625

To learn more, visit lotuscannabis.ca and follow the Lotus Cannabis Co. brand on social media.

Instagram: @lotuscannabisco
Twitter: @lotuscannabisco
LinkedIn: @lotuscannabisco
Facebook: @lotuscanna

Forward-Looking Information:

This document includes certain statements that are not descriptions of historical facts but are forward-looking statements. Such statements include, among others, those concerning our expected financial performance and strategic and operational plans, our future operating results, our expectations regarding the market for medical and recreational cannabis products, our expectations regarding the continued growth of the medical and recreational cannabis market, as well as all assumptions, expectations, predictions, intentions, or beliefs about future events. Users are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause our actual results to differ materially from those anticipated, expressed or implied in the forward-looking statements. These risks and uncertainties have not been documented or mentioned in this document nor other communications made by the company. The words “believe,” “expect,” “anticipate,” “project,” “targets,” “optimistic,” “intend,” “aim,” “will” or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Generated a Fourteenth Consecutive Quarter of Positive Free Cash Flow

VANCOUVER, BC, Dec. 15, 2022 /CNW/ – C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company“), a vertically integrated cannabis company, today announced its interim financial statements and management discussion and analysis for the third quarter ended October 31, 2022. The Company’s Q3 financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP“). All currency is reported in U.S. dollars.

Q3 Financial Highlights (August 1, 2022 to October 31, 2022):

• Revenue of $7.2 million – up 0.4% sequentially (note – State of Nevada cannabis sales were down 14.7% over the comparative period¹)
• Gross Margin of 54.2% – up 40 basis points sequentially
• Adjusted EBITDA² of $2.2 million – a 30% EBITDA Margin, in line with the previous three quarters
• Income from Operations of $1.4 million, $4.6 million year-to-date
• Net Income of $0.2 million for the quarter; Earnings Per Share of $0.02 year-to-date
• Cash Flow from Operations of $1.5 million – the 14^th consecutive quarter of positive Free Cash Flow; $4.8 million year-to-date
• Total Liabilities reduced by $1.0 million; $3.3 million year-to-date

Q3 Management and Operational Commentary:

“We are pleased to once again report strong results, generating another profitable bottom-line and positive cash flow quarter, despite continued industry and macro headwinds,” stated CEO and President, Sonny Newman. “The Nevada market experienced a 14.7% decline in cannabis sales quarter-over-quarter. However, our stable revenue and high margin profile highlight our ability to mitigate state-level and industry pricing pressures. The recent industry shift to a focus on generating positive cash flow further validates our stated strategy of deleveraging our balance sheet and generating meaningful cash flow. This focus over the past three years has us well positioned to take advantage of strategic opportunities in the current environment that will create value for our shareholders.”

C21’s Q3 revenue of $7.2 million was up 0.4% sequentially, outperforming Nevada market sales which saw an overall decline of 14.7% in total sales over the same period². The stability in Q3 sales is attributed to a 5% increase in transaction volume (126,000 total) over the previous quarter and continued ramp of wholesale, offset by a smaller average basket size resulting in 1.5% decline in retail sales.

Gross Margin was 54.2%, up 40 basis points from the previous quarter. The Company generated $2.2 million of Adjusted EBITDA¹ – a 30% EBITDA Margin, consistent with the previous three quarters.

C21 reported Q3 Net Income of $0.2 million, $2.4 million year-to-date or $0.02 earnings per share.

Cash Flow from Operations was $1.5 million – the fourteenth consecutive quarter of positive Cash Flow from Operations. Cash Flow from Operations year-to-date was $4.8 million.

Cash at the end of Q3 was $2.3 million, flat from Q2. The Company’s senior secured note was reduced by $1.5 million in Q3 and Total Liabilities have been reduced by $3.3 million year-to-date.

Subsequent to the quarter, the Company has paid down its senior secured note by an additional $1.0 million, with $2.5 million outstanding as of December 2, 2022. As well, Silver State has experienced an increase in wholesale demand at the start of Q4, including for the Company’s branded Phantom Farms flower.

Non-GAAP Measures:

“Adjusted EBITDA” is supplemental, non-GAAP financial measures. The Company defines EBITDA as earnings before depreciation and amortization, depreciation and interest in cost of sales, income taxes, and interest. Additionally, the Company’s Adjusted EBITDA presented above excludes accretion, loss from discontinued operations, one-time transaction costs and all other non-cash items. The Company has presented “Adjusted EBITDA” because its management believes it is a useful measure for investors when assessing and considering the Company’s continuing operations and prospects for the future.  Furthermore, “Adjusted EBITDA” is a commonly used measurement in the financial community when evaluating the market value of similar companies. “Adjusted EBITDA” is not a measure of performance calculated in accordance with GAAP, and these metrics should not be considered in isolation of, or as a substitute for, the measurement of the Company’s performance prepared in accordance with GAAP. “Adjusted EBITDA,” as calculated and reconciled in the table above, may not be comparable to similarly titled measurements used by other issuers and is not necessarily a measure of the Company’s ability to fund its cash needs. Figures have been restated to match current presentation.

Adjusted EBITDA:

Q3 Balance Sheet Summary:

___________________________

About C21 Investments Inc.

C21 Investments Inc. is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry-leading retail revenues with high-growth potential multi-market branded consumer packaged goods. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Based in Vancouver, Canada, additional information on C21 can be found at www.sedar.com and www.cxxi.ca.

Cautionary Statement:

Certain statements contained in this news release may constitute forward-looking statements within the meaning of applicable securities legislation. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Forward looking statements in this news release include, but are not limited to, the Company’s positioning to act on strategic opportunities in the current industry environment and the Company’s continued ability to mitigate state-level and industry pricing pressures.

The forward-looking statements contained in this news release are based on certain key expectations and assumptions made by the Company, including, without limitation, the ability of the Company’s management to execute its business strategy, objectives and plans.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks and uncertainties arising from general business, economic, competitive, political and social uncertainties; the impact of the COVID-19 pandemic on the Company’s operations and other factors, many of which are beyond the control of the Company

The forward-looking statements contained in this news release represent the Company’s expectations as of the date hereof and are subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE C21 Investments Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

EXOTIC AND UNIQUE GENETICS GROWN IN LIMITED QUANTITY BATCHES FOR CONSUMERS SEEKING AN ELEVATED CANNABIS EXPERIENCE

DELTA, British Columbia, Nov. 09, 2022 (GLOBE NEWSWIRE) — Pure Sunfarms Corp. (“Pure Sunfarms”), a wholly owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF), further expands its brand portfolio by introducing Soar, a cannabis brand designed to deliver an elevated cannabis experience with limited quantity batches of exotic and unique genetics that are hand-harvested, hang-dried, and hand-detailed.

Soar offers dried flower that is thoughtfully selected, thoroughly tended to, and carefully sorted to ensure only the best buds make it through to each finished 7g package. Based on the expression of cultivars and their distinctive aroma profiles, each strain is reviewed and assigned to an aroma collection—citrus, cake, fruit or gas—which plays an important role in understanding the cultivar and potential experience, and allows the consumer to choose the strain that appeals to them most.

“Soar is joining our family of brands, which includes our BC grown flagship brand, Pure Sunfarms, and our newly introduced, bulk-sized value brand, the Original Fraser Valley Weed Co.,” says Mandesh Dosanjh, President and CEO, Pure Sunfarms. “The Soar brand complements the portfolio by offering select cultivars chosen for their unique characteristics, hang-dried and presented through our aroma collections for an elevated dried flower experience. We’re excited about our newest addition to round out our offerings for the Canadian cannabis consumer.”

Soar’s initial limited batch offering includes 7g packages of:

Pineapple God (Potency: 22-28% THC, Aroma Collection: Fruit): High-THC indica-leaning Pineapple God is one of Soar’s fruit-aroma cultivars. This plant offers stacked colas of sticky green, pink and purple buds with exotic aromas of tropical fruit from the dominant terpenes: caryophyllene and humulene. Pineapple God is a potent God Bud cross with aromatic Black Cherry Punch.

Cherry Do-Si-Dos (Potency: 22-28% THC, Aroma Collection: Fruit): A high-THC indica, Cherry Do-Si-Dos is part of Soar’s fruit collection, showcasing uncompromising flavours that are equal parts floral, fruity, and funky. A cross that shares a lineage with the dank Dosidos, it produces dense and dark, trichome-abundant buds.

Alien Fuel (Potency: 20-26% THC, Aroma Collection: Citrus): Part of our citrus aroma collection, Alien Fuel is a potent, hybrid strain featuring an attractive pale green flower with purple tips, frosty buds with short bright orange hairs. A cross of high-octane Jet Fuel Gelato and the potent Pacific Northwest genetic MAC 1, its flowers deliver a balance of citrus and herbal aromas from the dominant terpenes of caryophyllene and linolool.

Soar products will be available in Alberta starting November 11, and in Ontario and BC in the weeks following.

About Pure Sunfarms

Pure Sunfarms is one of the largest cannabis operations in the world with 2.2 million square feet of greenhouse space in Delta, British Columbia. The company currently operates within 1.65 million square feet, and has capacity to produce, sell and distribute 112,500 kilograms of high-quality, BC-grown dried flower annually for Canadian recreational and international markets, with the ability to expand annual output to 150,000 kilograms as needed. The company brings together decades of agricultural and legacy cultivation experience with best-in-class, large scale operational expertise, and is Canada’s top-selling brand.

Pure Sunfarms products are available in Ontario, British Columbia, Alberta, Saskatchewan, Manitoba, Yukon, Northwest Territories, New Brunswick, and Newfoundland and Labrador at participating retailers and online through each region’s respective distributor where applicable. Pure Sunfarms also provides cannabis to its affiliate ROSE LifeScience in Québec, other licensed producers in Canada and is EU GMP certified to export product internationally.

Pure Sunfarms is the licensed producer of record for Pure Sunfarms, The Original Fraser Valley Weed Co., Soar, and is Cookies sun-grown partner in Canada. Pure Sunfarms is a wholly owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF).

www.puresunfarms.com

Media Contact

Danielle Allore
Communications Manager
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Launch marks the initial phase in multi-state agreement with planned expansion into Pennsylvania

PHOENIX, Oct. 06, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced the Massachusetts launch of Black Buddha Cannabis, a Black and woman-owned and led, environmentally conscious, social impact driven cannabis wellness brand.

Roz McCarthy is the driving force and founder of Black Buddha Cannabis, as well as Minorities for Medical Marijuana Inc. which advocates for equity and diversity in the nascent cannabis marketplace. Both organizations originated from the personal needs and experiences of McCarthy, who found cannabis instrumental to her healing journey after a car accident. Her brand seeks to promote optimal wellness across every aspect of life and support each patient or consumer to achieve their potential and live with passion and purpose.

The initial experience-based product line, Blyss, could support euphoric and positive effects. The products are primarily built around a sativa-leaning, hybrid flower that creates an uplifting blissful feeling with an array of sweet aromas in the following offerings:

• Blyss Flower—an eighth of expertly grown, premium cannabis;
• Blyss Chyllum—a 100-percent recyclable glass chillum, packed with 0.35g of flower; and
• Blyss Vape—a vape containing 300mg of a 3:1 THC:CBD ratio that is rich in beta-caryophyllene.

“Adding Black Buddha Cannabis to our diverse and innovative product portfolio available across the state is a testament to the success of our distinctive brand partner model,” said Gary Santo, Chief Executive Officer of TILT Holdings. “Black Buddha Cannabis is our eighth brand partner and the sixth brand we’ve brought to Massachusetts, further demonstrating our commitment to diversity in cannabis and the availability of quality products for patients and consumers. With our operational expertise, we believe a purpose-driven, environmentally conscious brand like Black Buddha Cannabis can scale and succeed in Massachusetts.”

“There is a dearth of equity-driven cannabis brands in Massachusetts, and Black Buddha Cannabis helps to fill that void,” said Roz McCarthy, Founder and Chief Executive Officer of Black Buddha Cannabis. “We’ve been careful to select partners who share our vision and commitment to product quality and integrity, and in TILT we’ve found a capable and trustworthy steward of our brand. Together we will break down silos within the industry and create a win-win for businesses and social equity efforts.”

Added Chris Kelly, Senior Vice President of Revenue Growth at TILT, “It’s our goal to provide our wholesale customers with a portfolio of in-demand products that will not only differentiate their dispensaries from the competition but also attract patient and consumer interest across demographics. Black Buddha Cannabis is a brand that has built a loyal following and is a strong addition to our portfolio.”

Black Buddha Cannabis is also expected to launch in the Pennsylvania market this fall through the brand’s exclusive partnership with TILT. Dispensaries in Massachusetts and Pennsylvania interested in Black Buddha Cannabis or other brand partner portfolio products from 1906, Airo, Her Highness, Highsman, Old Pal, Timeless Refinery, or Toast should contact our wholesale team to order or save a spot on our Launch List.

To keep up-to-date on progress, follow TILT and Black Buddha Cannabis on social media:
Instagram: @tiltholdings and @BlackBuddhaCannabis
Twitter: @TILT_Holdings

About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 37 states in the U.S., as well as Canada, Israel, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.

About Black Buddha Cannabis 
Black Buddha Cannabis establishes a new paradigm for the industry as a black-owned, environmentally conscious, wellness-focused, and social equity-driven brand. Black Buddha Cannabis’ premiere lifestyle and wellness products will be found at leading dispensaries across the country through state-by-state brand partnerships with equitable manufacturers, cultivators, and operators. Currently available in Ohio, Black Buddha Cannabis expects to have products initially available in California, Michigan, Nevada, Massachusetts, and Pennsylvania. To learn more about Black Buddha Cannabis please visit https://blackbuddhacannabis.co.

Forward-Looking Information
This news release contains forward-looking information and statements (together, “forward-looking information”) under applicable Canadian and U.S. securities laws which are based on current expectations. Forward-looking information is provided for the purpose of presenting information about TILT management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, the expected performance and success of the collaboration between TILT and Black Buddha Cannabis, planned expansion and timing of Black Buddha Cannabis into the Pennsylvania market, anticipated development, timing and release of future product offerings, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies, and outlook of TILT, and includes statements about, among other things, future developments, the future operations, strengths and strategy of TILT. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “will”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.

Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that it will be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of risk factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking information. Such risk factors include, but are not limited to, those described under the heading “Risk Factors” in Amendment No. 2 to the Form 10 Registration Statement filed by TILT with the United States Securities and Exchange Commission and on SEDAR at www.sedar.com.

Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
[email protected]

Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
[email protected]
720.330.2829

Media Contact:
Leland Radovanovic
Trailblaze
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

New Branded Cannabis Product Line Diversifies Company Product Offerings; Compliments Pharmaceutical Research

VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announced today the launch of the Company’s new product line, Flōs, a branded line of flower and pre-rolled cannabis products.

“Our Flōs line provides consumers with high-quality cannabis products without paying top shelf prices, and further expands our product category to capitalize on the massive market growth within California,” said Doug Chloupek, CEO and Founder of Juva. “We’re thrilled that the completion of our Stockton cultivation facility construction has doubled our output capacity, creating space for us to offer new consumer packaged goods that our customers are requesting.”

Flōs is Latin for blossom, or flower, and the unique beauty of the cannabis flower is on full display with Juva’s new product line. Featuring eighth ounce quantities, pre-rolls in one gram quantity, and half ounces of flower products, these meticulously-selected cultivars are budget-friendly without sacrificing quality.

The Flōs flower line is available for distribution throughout the entire state of California, and is also available through Juva Delivery, which is a division of vertically integrated Juva Life, Inc. Juva Delivery also offers contactless pre-payment options through Paytender, a secure, fee-free online payment service. The Flōs flower line will also be featured in the future at the Company’s upcoming retail store, which has been approved for licensing by the City of Redwood City, and is currently under construction.

Each Flōs product begins with the highest quality cannabis cultivars grown at the Company’s 30,000-square-foot Stockton, California, cannabis cultivation facility. Once harvested and cured, the material is then moved to Juva’s distribution division for final processing and statewide distribution. To find available products locally in the San Francisco Peninsula area, visit here.

ON BEHALF OF THE BOARD,

-Doug Chloupek-

Doug Chloupek, CEO and Founder

Juva Life Inc.

[email protected]

About Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRA: 4VV)

Juva Life is employing state-of-the-art science to discover, develop and commercialize safe and effective wellness and pharmaceutical products, in both the cannabis consumer segment as well as the non-cannabinoid based medical industry. The Company is successfully executing against its 2018 roadmap, initially starting with standardization of cultivation, extraction, and formulation to offer consumers reproducible benefits. Juva is building upon these natural product process chemistry skills, to now include discovery pharmacology. The Company will leverage revenue derived from its retail operations to advance its consumer and clinical development efforts of Juva-019 and Juva-041, as well as other potentially valuable non-cannabinoid bioactives with significant consumer and pharma products applications. Juva is working to bring the Cannabis market face to face with the sector’s next generation investment grade business model. Find out more at:https://juvalife.com/.

For further information, please contact:

Juva Life Investor Relations

Tel: +1 833-333-5882 (JUVA)

Email: [email protected]

Forward Looking Statement

This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; product development, commercialization strategy and future collaborations.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s management discussion and analysis for year ended December 31, 2020 under the heading “Risks and Uncertainties”. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

NORWOOD, Mass., Aug. 30, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD, OTCQX: MRMD), a leading multi-state cannabis operator (“MSO”) focused on improving lives every day, today announced the launch of Nature’s Heritage “LIVE Flower,” the freshest cannabis flower available. Nature’s Heritage “LIVE Flower” buds are bigger and brighter than conventional flower, bursting with more vibrant colors and stronger aromas, and delivering a smoother smoke.

The unparalleled freshness of Nature’s Heritage “LIVE Flower” is made possible through MariMed’s proprietary FreshCure curing process, which flash-freezes Nature’s Heritage craft flower within hours of being trimmed from the plant, locking in the natural terpenes and cannabinoid profiles. The flower is further refined through the Company’s proprietary barrel-cure guidelines specific to each unique flower strain to achieve optimal moisture levels. Nature’s Heritage “LIVE Flower” is packaged and sold in heavy, opaque glass jars featuring an extra-thick sealing membrane designed to prevent light and oxidation of the plant.

“We are very excited about the launch of Nature’s Heritage ‘LIVE Flower,’” said MariMed Chief Operating Officer Tim Shaw. “Experienced consumers will immediately recognize that our FreshCure curing process delivers the freshest cannabis flower and biggest, brightest, most colorful, and smoothest smoking buds they’ve ever experienced. The feedback we have received from dispensary owners, budtenders, and influencers has been overwhelming, and we can’t wait for people to try it for themselves.”

The FreshCure curing process eliminates approximately two-to-three weeks ordinarily required to dry traditional flower. As a result, Nature’s Heritage “LIVE Flower” arrives at dispensaries at its peak freshness. Because of its unique composition and texture, Nature’s Heritage “LIVE Flower” is best enjoyed in blunts, bongs, and bowls.

Nature’s Heritage “LIVE Flower” was launched in Massachusetts this month at MariMed’s Panacea Wellness dispensary in Middleborough. It will be distributed through approximately 25 other select dispensaries throughout Massachusetts over the next month. MariMed also expects to distribute it in the Company’s other wholesale markets, including Delaware, Illinois, and Maryland, in the future.

MariMed will continue cultivating and distributing its top-selling and award-winning traditional Nature’s Heritage flower and concentrates that consumers throughout New England have come to love.

ABOUT MARIMED
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

For More Information, Contact:

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: [email protected]
Phone: (781) 277-0007

Company Contact:
Howard Schacter
Chief Communications Officer
Email: [email protected]
Phone: (781) 277-0007

Media Contact:
Trailblaze PR
Email: [email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

LONDON–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European medical cannabis leader Cansativa GmbH (“Cansativa Group” or “Cansativa”) to supply EU-GMP quality THC dried flower strains cultivated from its Portuguese operations at Holigen. This new supply agreement marks one of the largest for medical cannabis to be exported from Portugal to serve the emerging European medical cannabis market.

Under the agreement terms, Akanda will supply Cansativa Group with two EU-GMP quality strains of dried THC flower for distribution and sale to all pharmacies in Germany through the Cansativa platform. The contract specifies initial deliveries of a minimum of 1,000 kilograms (approximately 2,200 pounds) over the first 12 months, with a right of first refusal (ROFR) to take on additional quantities that could result in the full capacity utilization of Holigen’s 2,000 kilograms per annum indoor production capacity. The initial shipment is anticipated to include up to 250 kilograms of each strain to be supplied no later than the fourth quarter of 2022.

“This supply agreement with Cansativa represents one of the largest supply agreements in the nascent European medical cannabis industry and is certainly Akanda’s most substantial commercial development to date,” said Tej Virk, Chief Executive Officer of Akanda. “Our EU GMP certified grow facility in Portugal has both the quality and scalability to meet the increasing demands for medical cannabis in fast-growing markets across the EMEA region, such as Germany. Once made available, our strains will rank among the highest THC level medical cannabis products available in the EU. We’re looking forward to a long-term relationship with the Cansativa Group, a professional and collaborative partner who shares our mission to expand access to medical cannabis to improve the quality of lives. The fact that we executed this supply agreement only two months after Akanda closed the acquisition of Holigen shows tremendous partnership and hard work on both sides.”

Cansativa is the leading importer and distributor of medical cannabis in Germany, with a distribution network in the country that includes direct connections to all pharmacies, many cannabis suppliers and distributors, as well as several pharmaceutical wholesalers. Cansativa is positioned as one-stop-shop and offers the biggest multi-brand medical cannabis portfolio in the market. Over the last five years Cansativa has partnered with most leading cannabis firms and has become one of the key players in the cannabis industry in Europe. Since the award of the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, Cansativa is the only company with approval for the distribution of medical cannabis from German cultivation.

About Akanda Corp.

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda’s portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa; Holigen, a Portugal-based cultivator, manufacturer and distributor with a prized EU GMP certified indoor grow facility; and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company’s seed-to-patient supply chain also includes partnerships with Cellen Life Sciences’ Leva Clinic, one of the first fully digital pain clinics in the UK, and other leading distributors of medical cannabis in Germany.

Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

CannabCo set to capture market with high THC Odourless Cannabis Products

BRAMPTON, ON, Nov. 30, 2021 /CNW/ – CannabCo Pharmaceutical Corp. (CannabCo), a Canadian company located in Brampton, Ontario, is pleased to announce a milestone achievement with the testing of one of the industry’s most potent cannabis strains at 41% total quantifiable cannabinoid content. The strain features a lab tested cannabinoid count of 40.59% with a THC rating of 35%. The main distinguishing feature of the strain, other than its high THC content, is that it was created with Purecann, CannabCo’s proprietary Odourless Cannabis technology.

Certificate of analysis for 41% Purecann strain. (CNW Group/CannabCo Pharmaceutical Corp.)

The deployment of Purecann makes the product virtually odourless when smoked or stored allowing for a reduced impact on others sensitive to the pungent odour of cannabis. This is an industry first and a product the company claims is sorely needed in the marketplace.

The company has developed and tested multiple Purecann strains ranging from under .3% for the smoke-able hemp market, with numerous strains in the 20-32% range, culminating to the highest THC range currently at 35%.

Currently the highest THC dry flower in the Ontario Cannabis Store lists at a maximum of 32% THC. Mark Pellicane, CannabCo’s CEO, thinks they can do better. “We are always pushing the limits with our technologies” said Pellicane, “With the demand for high THC strains, it made sense to target the same in odourless variants and our result is one of the highest THC strains produced to date”. Pellicane also stated that the company has multiple strains in the high 30’s in the works, as well as market specific strains with targeted THC levels and cannabinoid profiles for specific markets and effects.

“We’ve taken the time during the COVID-19 pandemic to developed products suitable for multiple target markets” said Mark Novak, the company’s COO. “For example, Israel currently has a THC cap on dry bud, so we’ve developed products specific to the 20-25% range in order to maximize consumer uptake for that specific medical and pending recreational markets”. The company has been approached for Purecann deployment in multiple markets such as the USA, EU, Israel, Australia, and South America.

The company intends to continue to develop innovative and first to market products, with its undisclosed technology and grow partner. CannabCo maintains full ownership and rights to Purecann and the odourless cannabis technology.

About CannabCo Pharmaceutical Corp.

CannabCo Pharmaceutical Corp. is a Canadian based full service cannabis technology company with operations in Brampton, Ontario.  The company has received its “Confirmation of Readiness” from Health Canada to become a licensed producer and is currently building out its pilot facility in the Brampton Area.  The company features a wide variety of proprietary developed technologies including PHOENIX for its cultivation initiatives claiming a high productivity and significantly lower cost per gram than traditional grows.  CannabCo is best known for its Purecann technology used for the production of Odourless Cannabis and more recently Odourless Tobacco.

Forward Looking Statements
This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Forward-looking statements may be identified by  statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts” and other similar expressions. Actual results and developments may differ materially from those contemplated by these statements. Although CannabCo believes that the expectations reflected in forward-looking statements in this press release are reasonable, there can be no assurance that such statements will prove to be accurate. Future events and results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements in this press release.  Comments and claims related to PHOENIX and PURECANN are based solely on that observed and the opinions of management as well as third party verifications provided to CannabCo from industry experts.

Contact:

CannabCo Pharmaceutical Corp.
[email protected]
www.cannabco.ca

SOURCE CannabCo Pharmaceutical Corp.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

By Rebecca Victoria Olmos | TheCannifornian.com Correspondent

I know of a cannabis customer that walks into the dispensary, doesn’t look at the menu, and tells the budtender, “Give me two really good 8ths.” He takes whatever the budtender provides and never complains.

That is certainly one way to do it. But for those that what to become a little more involved with the process, here are a few things to consider when choosing your next strain. 

Knowing how much you’d like to spend can save you trouble at the end of the transaction. Be prepared that taxes in the state of California can be anywhere up to 38%.

I only mention this because it will be your first step in narrowing down your choices. You can find excellent quality buds within any budget. And don’t worry, price doesn’t always equate to the quality of the flower or the effects you’ll get.

Indica, sativa, or hybrid are the classic categories of flowers. Sativa is known for its more uplifting effects, indica for its sedating feelings, and hybrids fall anywhere in between those two. THC percentages have also traditionally been the defining factor in users knowing how potent a strain will be.

However, a strain’s terpene profile and cannabinoid content tends to better gauge how it will affect an individual. Flower high in limonene can provide energizing feelings, and myrcene dominate strains may feel more relaxing.

They say “the nose knows,” meaning if you like the smell, you’ll most likely enjoy the effects. But, in the recreational cannabis market, all buds are prepackaged. In the covid era, even if a dispensary offers sample jars, you can’t smell the flower most of the time. Refer back to previous information about terpenes. Budtenders should be also able to help you find this information.

What values are important to you? Women-owned? Equity brand? Environmentally friendly? Community outreach? Cannabis companies stand for much more than just weed these days. Spend your dollar wisely.

If you’re new on your strain journey, keep a journal with strain names, brands, terpenes, cannabinoids and how they made you feel. If you can tell a budtender what you didn’t like, they can help steer you towards a strain you might enjoy better.

And if all of it still overwhelms you, ask your budtender what they’re smoking or what other customers have been enjoying. An open mind and curiosity are essential to finding a perfect strain for you.